Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Geneva | OTHER |
Not provided
Not provided
Not provided
Not provided
Shift workers are a growing population. It is well established that these workers face an increased risk of developing chronic diseases, but the underlying mechanisms remain debated. Various factors such as internal circadian desynchronization, unhealthy lifestyle behaviours, and lack of sleep interact in complex ways. Recently, it has been suggested that the gut microbiota (GM) may play an important role in this increased risk.
The goal of this study is to describe the variations of the GM composition in shift workers across three different rotating weekly shifts (morning, afternoon, night) and to measure the impact of a 3- week walnuts supplementation intervention consisting in a controlled experimental study.
Therefore, we propose a 6-weeks study including an observational and an experimental part. First, in the observational part, we will compare the gut microbiota of shift workers across three shifts (morning, afternoon and night). In the second part of the study, participants will add to their usual intakes a daily serving of nuts (30g). Again, we will compare the gut microbiota composition across the three types of shifts. During the study, participants will record their food intake, sleep and defecation time. We will also monitor their blood glucose levels continuously during the 4 first weeks of the study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention walnuts | Experimental | During the 3 last weeks of the study, the participants will eat a 30g daily walnut serving |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Walnuts | Dietary Supplement | 30g of plain walnuts in addition to habitual food intakes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in gut microbiota composition between the first and last day of each type of shift (observation phase) | Change in relative abundance of bacteria phyla between the first and last day of each type of shift (AM, PM, N). Assessed by 16S rRNA sequencing approach. | 3 weeks (6 measurements over time) |
| Change in gut microbiota composition between the first and last day of each type of shift (observation vs intervention) | Change in relative abundance of bacteria phyla between the first and last day of each type of shift (AM, PM, N). Assessed by 16S rRNA sequencing approach. | 6 weeks (12 measurements over time) |
| Measure | Description | Time Frame |
|---|---|---|
| Area under the blood glucose curve between each type of shift | Area under the blood glucose curve between each type of shift (AM, PM, N). Measured using a continuous glucose monitoring. | 3 weeks |
| Area under the blood glucose curve in AM shift (observation vs intervention) |
| Measure | Description | Time Frame |
|---|---|---|
| Mean weekly frequency of defecation between each type of shift | 6 weeks |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| School of Health Sciences Geneva | Geneva | Carouge | 1227 | Switzerland |
De-identified individual participant data for all primary and secondary outcome measure will be made available.
Not provided
Data will be available within 12 months of study completion
At the end of the project the data will be deposited in the Yareta repository developed by the University of Geneva OR in an institutional repository. This choice will ensure that data is archived and shared in accordance with FAIR principles.
Not provided
Not provided
| ID | Term |
|---|---|
| D064806 | Dysbiosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
3 weeks of observation 3 weeks of intervention
Not provided
Not provided
Not provided
Not provided
Area under the blood glucose curve during the morning shift (AM) during the observation and the intervention. Measured using a continuous glucose monitoring. |
| week 1 vs 4 |